SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Karmali M.A. (2004) Infection by Shiga toxin-producing Escherichia coli: an overview. Mol Biotechnol 26: 11722.
  • 2
    Tarr P.I., Gordon C.A., Chandler W.L. (2005) Shiga-toxin-producing Escherichia coli and haemolytic uraemic syndrome. Lancet 365: 107386.
  • 3
    Jacewicz M., Clausen H., Nudelman E., Donohue-Rolfe A., Keusch G.T. (1986) Pathogenesis of shigella diarrhea. XI. Isolation of a shigella toxin-binding glycolipid from rabbit jejunum and HeLa cells and its identification as globotriaosylceramide. J Exp Med 163: 1391404.
  • 4
    Lindberg A.A., Brown J.E., Stromberg N., Westling-Ryd M., Schultz J.E., Karlsson K.A. (1987) Identification of the carbohydrate receptor for Shiga toxin produced by Shigella dysenteriae type 1. J Biol Chem 262: 177985.
  • 5
    Lingwood C.A., Law H., Richardson S., Petric M., Brunton J.L., De Grandis S., Karmali M. (1987) Glycolipid binding of purified and recombinant Escherichia coli produced verotoxin in vitro. J Biol Chem 262: 88349.
  • 6
    Saxena S.K., O'Brien A.D., Ackerman E.J. (1989) Shiga toxin, Shiga-like toxin II variant, and ricin are all single-site RNA N-glycosidases of 28 S RNA when microinjected into Xenopus oocytes. J Biol Chem 264: 596601.
  • 7
    Endo Y., Tsurugi K., Yutsudo T., Takeda Y., Ogasawara T., Igarashi K. (1988) Site of action of a Vero toxin (VT2) from Escherichia coli O157:H7 and of Shiga toxin on eukaryotic ribosomes. RNA N-glycosidase activity of the toxins. Eur J Biochem 171: 4550.
  • 8
    Takeda Y., Kurazono H., Yamasaki S. (1993) Vero toxins (Shiga-like toxins) produced by enterohemorrhagic Escherichia coli (verocytotoxin-producing E. coli). Microbiol Immunol 37: 5919.
  • 9
    Ostroff S.M., Tarr P.I., Neill M.A., Lewis J.H., Hargrett-Bean N., Kobayashi J.M. (1989) Toxin genotypes and plasmid profiles as determinants of systemic sequelae in Escherichia coli O157:H7 infections. J Infect Dis 160: 9948.
  • 10
    Scotland S.M., Willshaw G.A., Smith H.R., Rowe B. (1987) Properties of strains of Escherichia coli belonging to serogroup O157 with special reference to production of Vero cytotoxins VT1 and VT2. Epidemiol Infect 99: 61324.
  • 11
    Hashimoto H., Mizukoshi K., Nishi M., Kawakita T., Hasui S., Kato Y., Ueno Y., Takeya R., Okuda N., Takeda T. (1999) Epidemic of gastrointestinal tract infection including hemorrhagic colitis attributable to Shiga toxin 1-producing Escherichia coli O118:H2 at a junior high school in Japan. Pediatrics 103: E2.
  • 12
    Tsuji T., Shimizu T., Sasaki K., Shimizu Y., Tsukamoto K., Arimitsu H., Ochi S., Sugiyama S., Taniguchi K., Neri P., Mori H. (2008) Protection of mice from Shiga toxin-2 toxemia by mucosal vaccine of Shiga toxin 2B-His with Escherichia coli enterotoxin. Vaccine 26: 46976.
  • 13
    Marcato P., Griener T.P., Mulvey G.L., Armstrong G.D. (2005) Recombinant shiga toxin B-subunit-keyhole limpet hemocyanin conjugate vaccine protects mice from shigatoxemia. Infect Immun 73: 65239.
  • 14
    Byun Y., Ohmura M., Fujihashi K., Yamamoto S., Mcghee J.R., Udaka S., Kiyono H., Takeda Y., Kohsaka T., Yuki Y. (2001) Nasal immunization with E. coli verotoxin 1 (VT1)-B subunit and a nontoxic mutant of cholera toxin elicits serum neutralizing antibodies. Vaccine 19: 206170.
  • 15
    Hovde C.J., Calderwood S.B., Mekalanos J.J., Collier R.J. (1988) Evidence that glutamic acid 167 is an active-site residue of Shiga-like toxin I. Proc Natl Acad Sci USA 85: 256872.
  • 16
    Jackson M.P., Deresiewicz R.L., Calderwood S.B. (1990) Mutational analysis of the Shiga toxin and Shiga-like toxin II enzymatic subunits. J Bacteriol 172: 334650.
  • 17
    Yamasaki S., Furutani M., Ito K., Igarashi K., Nishibuchi M., Takeda Y. (1991) Importance of arginine at position 170 of the A subunit of Vero toxin 1 produced by enterohemorrhagic Escherichia coli for toxin activity. Microb Pathog 11: 19.
  • 18
    Ohmura M., Yamasaki S., Kurazono H., Kashiwagi K., Igarashi K., Takeda Y. (1993) Characterization of non-toxic mutant toxins of Vero toxin 1 that were constructed by replacing amino acids in the A subunit. Microb Pathog 15: 16976.
  • 19
    Ishikawa S., Kawahara K., Kagami Y., Isshiki Y., Kaneko A., Matsui H., Okada N., Danbara H. (2003) Protection against Shiga toxin 1 challenge by immunization of mice with purified mutant Shiga toxin 1. Infect Immun 71: 32359.
  • 20
    Wen S., Teel L., Judge N., O'brien A.D. (2006) Genetic toxoids of Shiga toxin types 1 and 2 protect mice against homologous but not heterologous toxin challenge. Vaccine 24: 11428.
  • 21
    Smith M.J., Teel L.D., Carvalho H.M., Melton-Celsa A.R., O'brien A.D. (2006) Development of a hybrid Shiga holotoxoid vaccine to elicit heterologous protection against Shiga toxins types 1 and 2. Vaccine 24: 41229.
  • 22
    Makino S., Watarai M., Tabuchi H., Shirahata T., Furuoka H., Kobayashi Y., Takeda Y. (2001) Genetically modified Shiga toxin 2e (Stx2e) producing Escherichia coli is a vaccine candidate for porcine edema disease. Microb Pathog 31: 18.
  • 23
    Gordon V.M., Whipp S.C., Moon H.W., O'Brien A.D., Samuel J.E. (1992) An enzymatic mutant of Shiga-like toxin II variant is a vaccine candidate for edema disease of swine. Infect Immun 60: 48590.
  • 24
    Bosworth B.T., Samuel J.E., Moon H.W., O'brien A.D., Gordon V.M., Whipp S.C. (1996) Vaccination with genetically modified Shiga-like toxin IIe prevents edema disease in swine. Infect Immun 64: 5560.
  • 25
    Arimitsu H., Tsukamoto K., Ochi S., Sasaki K., Kato M., Taniguchi K., Oguma K., Tsuji T. (2009) Lincomycin-induced over-expression of mature recombinant cholera toxin B subunit and the holotoxin in Escherichia coli. Protein Expr Purif 67: 96103.
  • 26
    Spizek J., Rezanka T. (2004) Lincomycin, clindamycin and their applications. Appl Microbiol Biotechnol 64: 45564.
  • 27
    Neri P., Nagano S.I., Yokoyama S., Dohi H., Kobayashi K., Miura T., Inazu T., Sugiyama T., Nishida Y., Mori H. (2007) Neutralizing activity of polyvalent Gb3, Gb2 and galacto-trehalose models against Shiga toxins. Microbiol Immunol 51: 58192.
  • 28
    Jackson M.P., Neill R.J., O'brien A.D., Holmes R.K., Newland J.W. (1987) Nucleotide sequence analysis and comparison of the structural genes for Shiga-like toxin I and Shiga-like toxin II encoded by bacteriophages from Escherichia coli 933. FEMS Microbiol Lett 44: 10914.
  • 29
    Yutsudo T., Nakabayashi N., Hirayama T., Takeda Y. (1987) Purification and some properties of a Vero toxin from Escherichia coli O157:H7 that is immunologically unrelated to Shiga toxin. Microb Pathog 3: 2130.